Skip to content

Clinical trials

Observational Mucopolysaccharidosis III trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis III Phase: Observational Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20102
20123
20131
20142
20151
20171
20181
20201
20211
20221
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting2
Terminated2
Unknown status2
Not yet recruiting1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Phoenix Nest3
Alexion Pharmaceuticals, Inc.2
Allievex Corporation2
Shire2
University of Minnesota2
Abeona Therapeutics, Inc1
Albert Einstein College of Medicine1
Lysosomal and Rare Disorders Research and Treatment Center, Inc.1
Nationwide Children's Hospital1
RTI International1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis III19
Mucopolysaccharidoses6
Mucopolysaccharidosis VI4
Leukodystrophy, Globoid Cell3
Mucopolysaccharidosis I3
Mucopolysaccharidosis II3
Mucopolysaccharidosis IV3
Sudden Infant Death3
Gaucher Disease2
Leukodystrophy, Metachromatic2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.